Jerrold Rosenbaum, MD

Dr. Jerrold Rosenbaum is a physician-scientist who is among the world’s leading authorities on mood and anxiety disorders, along with co-founding several neuropsychiatric biotechnology organizations. He currently serves as the Director of the Center for the Neuroscience of Psychedelics at the Massachusetts General Hospital (MGH), which seeks to understand how psychedelics impact the brain and elucidate potential therapeutic benefits of psychedelic therapies. He co-founded Sensorium, Psy Therapeutics, and Entheos Labs, organizations advancing innovative therapeutics within the neuropsychiatric space. In addition, Dr. Rosenbaum is the Stanley Cobb Professor of Psychiatry at Harvard Medical School and Psychiatrist‐in-Chief Emeritus of the Department of Psychiatry at MGH, where he led the department for two decades and oversaw hundreds of clinicians, researchers and trainees. Dr. Rosenbaum received his undergraduate degree from Yale College and his medical degree from Yale School of Medicine. He completed his residency and fellowship in Psychiatry at Massachusetts General Hospital, Harvard Medical School.